NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 58 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,431 | -50.6% | 10,467 | -0.5% | 0.00% | – |
| Q2 2022 | $11,000 | -57.7% | 10,521 | +391.6% | 0.00% | – |
| Q1 2021 | $26,000 | -70.1% | 2,140 | -65.6% | 0.00% | – |
| Q4 2020 | $87,000 | +155.9% | 6,217 | +129.1% | 0.00% | – |
| Q3 2020 | $34,000 | -27.7% | 2,714 | -24.6% | 0.00% | – |
| Q2 2020 | $47,000 | +261.5% | 3,600 | +194.8% | 0.00% | – |
| Q1 2020 | $13,000 | -13.3% | 1,221 | 0.0% | 0.00% | – |
| Q4 2019 | $15,000 | +400.0% | 1,221 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | – | 1,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,225,000 | $15,080,000 | 2.22% |
| EcoR1 Capital, LLC | 3,122,704 | $38,440,000 | 1.70% |
| Redmile Group, LLC | 4,117,569 | $50,687,000 | 0.71% |
| HighVista Strategies LLC | 71,235 | $877,000 | 0.65% |
| Boxer Capital, LLC | 1,501,058 | $18,478,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $47,046,000 | 0.20% |
| Sio Capital Management, LLC | 38,312 | $472,000 | 0.10% |
| Highland Private Wealth Management | 46,999 | $579,000 | 0.10% |
| Point72 Asset Management, L.P. | 1,308,600 | $16,109,000 | 0.08% |
| Granahan Investment Management | 200,518 | $2,468,000 | 0.05% |